close
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

PROCEPT BioRobotics Corporation - Common Stock (NQ:PRCT)

27.80 -0.32 (-1.16%)
Streaming Delayed Price Updated: 3:25 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about PROCEPT BioRobotics Corporation - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
Procept BioRobotics Shares Are Higher Today, CEO Touts 'Strong Surgeon Interest' ↗
Procept BioRobotics Corp (NASDAQ: PRCT) shares are trading higher after the company announced fourth-quarter (Q4) FY23  
Via Benzinga
News headline image
Demystifying PROCEPT BioRobotics: Insights From 4 Analyst Reviews ↗
 
Via Benzinga
News headline image
PROCEPT BioRobotics® Announces Preliminary Fourth Quarter Revenue of $43.3 million to $43.6 million
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics Stock Scores Rising Relative Strength ↗
The Relative Strength (RS) Rating for PROCEPT BioRobotics stock headed into a new percentile Tuesday, as it got a lift from 70 to 77. 
Via Investor's Business Daily
News headline image
PROCEPT BioRobotics to Present at the 35ᵗʰ Annual Piper Sandler Healthcare Conference in New York City
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® Reports Third Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
The 7 Best Tech Stocks To Buy Now: October 2023 ↗
Although the innovation sector got overheated, certain underappreciated ideas make up the best tech stocks to buy now. 
Via InvestorPlace
News headline image
PROCEPT BioRobotics to Report Third Quarter 2023 Financial Results on November 1, 2023
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
The National Institute for Health and Care Excellence Endorses Aquablation® Therapy with "Standard Arrangements" Recommendation
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics Announces New Corporate Headquarters in San Jose
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® Receives U.S. FDA Investigational Device Exemption to Investigate Aquablation® Therapy for Prostate Cancer
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® Announces First Commercial Aquablation Therapy Procedures in Japan
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics to Present at the 2023 Wells Fargo Healthcare Conference in Boston
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
NorthShore University HealthSystem offers expanded access to treat most common prostate ailment
Highland Park Hospital adds second AquaBeam system, Swedish Hospital installs first 
From PROCEPT BioRobotics; NorthShore University HealthSystem
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 11, 2023 ↗
 
Via Benzinga
News headline image
PROCEPT BioRobotics Corporation Announces Pricing of Upsized Offering of Common Stock
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics Corporation Announces Proposed Offering of Common Stock
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics® Reports Second Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
PROCEPT BioRobotics to Report Second Quarter 2023 Financial Results on July 27, 2023
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For May 31, 2023 ↗
 
Via Benzinga
News headline image
7 Growth Stocks That Could Double Your Money in 2023 ↗
For investors that really want to roll the dice, these are the enticing growth stocks that could double your money. 
Via InvestorPlace
News headline image
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
Intel, Saia, Charter Communications And Other Big Stocks Moving Higher On Friday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 100 points on Friday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Five-Year Data from the WATER II Study Demonstrate Aquablation Therapy Delivers Significant Durable Improvement of Benign Prostatic Hyperplasia Symptoms while Preserving Sexual Function in Men with Large Prostates
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against PROCEPT BioRobotics Corporation and Encourages Investors with Losses to Contact the Firm
From The Schall Law Firm
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Shares of Procept Biorobotics Were Slumping Thursday ↗
The company released first-quarter earnings on Thursday morning. 
Via The Motley Fool
News headline image
PROCEPT BioRobotics Reports First Quarter 2023 Financial Results and Increases 2023 Revenue Guidance
From PROCEPT BioRobotics
Via GlobeNewswire
News headline image
Why NETGEAR Shares Are Trading Lower By 18%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Evelo Biosciences, Inc. (NASDAQ: EVLO) jumped 147.9% to $0.2479. Evelo Biosciences shares dropped 33% on Wednesday after the company announced top-line data from the fourth cohort of its... 
Via Benzinga
News headline image
Earnings Scheduled For April 27, 2023 ↗
Companies Reporting Before The Bell • Cazoo Gr (NYSE:CZOO) is expected to report earnings for its first quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Starting at $3.75/week.

Subscribe Today